Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension
NCT05918458 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-06-26
Summary
Taking part in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of pulmonary hypertension patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future pulmonary hypertension patients.
Conditions
- Pulmonary Hypertension
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-31
- Primary Completion
- 2025-07-31
- Completion
- 2026-07-31
Countries
- United States
Study Locations
More Related Trials
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
NCT00423202 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT07073820 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)
NCT00832507 ·Status: TERMINATED ·Phase: PHASE2
-
Trans-pulmonary Biomarkers in Pulmonary Hypertension
NCT01961232 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of CS1 in Subjects With Pulmonary Arterial Hypertension
NCT05224531 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.
NCT05908019 ·Status: UNKNOWN ·Phase: NA
-
Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH
NCT03841344 ·Status: UNKNOWN ·Phase: NA
-
A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension
NCT00853112 ·Status: TERMINATED ·Phase: PHASE2
-
Endothelial Function in Patients With Pulmonary Arterial Hypertension
NCT01317134 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenomics in Pulmonary Arterial Hypertension
NCT00593905 ·Status: WITHDRAWN
-
Hormonal, Metabolic, and Signaling Interactions in PAH
NCT01884051 ·Status: RECRUITING
-
A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults
NCT06493461 ·Status: TERMINATED ·Phase: PHASE1
-
Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH
NCT03888365 ·Status: COMPLETED
-
Neuromodulation in Patients With Pulmonary Arterial Hypertension
NCT06802380 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
NCT01051960 ·Status: COMPLETED ·Phase: PHASE4
-
Selonsertib in Adults With Pulmonary Arterial Hypertension
NCT02234141 ·Status: COMPLETED ·Phase: PHASE2
-
Carvedilol PAH A Pilot Study of Efficacy and Safety
NCT02120339 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT03496207 ·Status: COMPLETED ·Phase: PHASE2
-
Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects
NCT03304548 ·Status: COMPLETED
-
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension
NCT03738150 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension
NCT05135000 ·Status: TERMINATED ·Phase: PHASE2
-
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
NCT05764265 ·Status: TERMINATED ·Phase: PHASE2
-
Endothelial Cell Activation and Total Pulmonary Resistance in PAH
NCT06035861 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants
NCT04955990 ·Status: TERMINATED ·Phase: PHASE4
-
Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension
NCT00313222 ·Status: COMPLETED ·Phase: PHASE3